Suprasorb® G Hydrogel Sheet Dressing
Suprasorb® G is a hydrogel sheet dressing with a high dynamic range of moisture response. Donates moisture and absorbs exudate in response to the wounds changing needs. Provides cooling pain relief.
• Cooling and soothing pain relief
• Atraumatic, pain free removal
• Responds to wound moisture requirements
• Donates or absorbs moisture as required
• Supports autolytic debridement
• Transparent for wound visualization
• Color change indicates when it is time to change dressing
Suprasorb® G is indicated for the management of dry to moderately exuding acute and chronic wounds.
Use under medical supervision if wound contamination or infection is suspected.
Store in a cool dry environment
|Bacteria or fluid barrier||●|
|Compatible w/ topicals||●|
|Conforms readily to wound||●|
|Intact when saturated||●|
|Moisture vapor permeable||●|
|Secondary dressing required||●|
|Usable on infected wounds||●|
|Variety of sizes||●|
|Educational Material Available|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Dry Skin Conditions
Non/Minimally Exudating Wounds
Prepare wound and periwound skin per current protocol. Open sterile pouch and remove dressing. Remove white release liner and apply to the wound surface.
Change dressing when color change approaches edges of the dressing (indicating pad saturation) or once per day to provide moisture to dry wounds or dry wound areas.
Suprasorb® G hydrogel sheet dressings may be held in place with secondary adhesive dressings (ex. Suprasorb® F), tape or bandages including compression bandages and multilayer compression bandaging systems (ex. Rosidal® TCS).
Dynamic moisture responsive hydrogel sheet with a bottom (white) release liner and removable (clear) film top.
L&R USA INC. (L&R) is part of a leading global medical device company, which has been delivering high quality healthcare products for over 160 years. L&R USA INC. is dedicated to providing health care professionals product solutions in the treatment of wounds, edema, venous disease, and lymphedema to improve patient care and outcomes.